By analyzing the utilization of monoclonal antibody drugs in sample hospitals in Shanghai in the past three years, the overall development of monoclonal antibody drugs was understood, so as to provide reference for clinical rational drug use.
The clinical sampling data of monoclonal antibody drugs in sample hospitals in Shanghai from 2019 to 2021 were collected from the Hospital Prescription Analysis System database of China National Pharmaceutical Industry Information Center to analyze the clinical application of monoclonal antibody drugs in the past three years.
From 2019 to 2021, the number of monoclonal antibody drugs prescriptions and antitumor drugs prescriptions in sample hospitals in Shanghai increased year by year, and the prescription amount fluctuated. The trend of the number of prescriptions and the amount of prescriptions in medical institutions at all levels was basically the same. From 2019 to 2021, trastuzumab, rituximab and bevacizumab had the highest cumulative number of prescriptions and amount of prescriptions. From the market share and year-on-year analysis, it could be seen that the compound growth rate of adalimumab is the fastest, which has reached 1 200%, and pertuzumab is the second fastest, which nearly 700%, meanwhile, the market share is also relatively high, nearly 15%. In 2021, the treatment of monoclonal antibody drugs in sample hospitals in Shanghai mainly focused on anti-tumor therapy. The indications with more prescriptions of monoclonal antibody drugs for tumor treatment were breast cancer, intestinal cancer and lymphoma, respectively. The drugs with the largest number of prescriptions were trastuzumab, pertuzumab, bevacizumab, rituximab and cetuximab.
Monoclonal antibody drugs has been widely used in clinical practice, and the use of monoclonal antitumor drugs is occupy a dominant position.
| 科 Family | 属数 Number of genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) | 属 Genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) |
|---|---|---|---|---|---|---|
| 鹅膏菌科Amanitaceae | 2 | 11 | 5.26 | 鹅膏菌属 Amanita | 10 | 4.78 |
| 小菇科 Mycenaceae | 2 | 12 | 5.74 | 丝盖伞属 Inocybe | 5 | 2.39 |
| 多孔菌科 Polyporaceae | 8 | 14 | 6.70 | 蜡蘑属 Laccaria | 5 | 2.39 |
| 红菇科 Russulaceae | 3 | 23 | 11.00 | 小皮伞属 Marasmius | 6 | 2.87 |
| 小菇属 Mycena | 11 | 5.26 | ||||
| 光柄菇属 Pluteus | 5 | 2.39 | ||||
| 红菇属 Russula | 17 | 8.13 | ||||
| 栓菌属 Trametes | 5 | 2.39 |